Avelumab

Phase 2UNKNOWN

0 watching 0 views this week⚡ Active

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Penile Cancer

Conditions

Penile Cancer, Penile Neoplasms, Penile Squamous Cell Carcinoma

Trial Timeline

Mar 12, 2019 → Sep 22, 2024

NCT ID

NCT03774901

About Avelumab

Avelumab is a phase 2 stage product being developed by Pfizer for Penile Cancer. The current trial status is unknown. This product is registered under clinical trial identifier NCT03774901. Target conditions include Penile Cancer, Penile Neoplasms, Penile Squamous Cell Carcinoma.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (13)

NCT ID	Phase	Status	Start	Completion	Indication
NCT05568407	Pre-clinical	Terminated	Jan 18, 2023	Jun 16, 2023	Bladder Cancer
NCT03617666	Phase 2	UNKNOWN	Sep 27, 2019	May 30, 2025	Hodgkin Lymphoma
NCT03719768	Phase 1	Completed	Jun 10, 2019	Aug 21, 2024	Leptomeningeal Metastases
NCT03774901	Phase 2	UNKNOWN	Mar 12, 2019	Sep 22, 2024	Penile Cancer
NCT03498196	Phase 1/2	Terminated	Dec 14, 2018	Dec 9, 2019	Bladder Cancer
NCT03395873	Phase 1	Terminated	Jan 29, 2018	May 15, 2019	Acute Myeloid Leukemia
NCT03267836	Phase 1	Terminated	Jan 10, 2018	Apr 6, 2023	Meningioma
NCT03399552	Phase 1/2	Completed	Dec 20, 2017	Jan 20, 2023	Malignant Mesothelioma (MPM)
NCT03046953	Phase 2	Completed	Dec 8, 2017	Jul 27, 2021	T-Cell Lymphoma Relapsed
NCT03050554	Phase 1/2	Terminated	Oct 26, 2017	Oct 7, 2019	Early Stage Non-Small Cell Lung Cancer
NCT03006848	Phase 2	Completed	Feb 16, 2017	Mar 18, 2020	Osteosarcoma
NCT02875613	Phase 2	Terminated	Jan 1, 2017	Apr 1, 2019	Nasopharyngeal Cancer
NCT02952586	Phase 3	Terminated	Nov 28, 2016	Aug 25, 2020	Squamous Cell Carcinoma of the Head and Neck

Competing Products

8 competing products in Penile Cancer

See all competitors

Product	Company	Stage	Hype Score
Avelumab + enfortumab vedotin	Astellas Pharma	Phase 2	52
Pembrolizumab + Standard of care therapy	Merck	Phase 2	52
Pembrolizumab	Merck	Phase 2	52
Arm A: Atezolizumab and Radiotherapy + Arm B: Atezolizumab	Roche	Phase 2	52
Placebo QHS and sildenafil and questionnaires + Sildenafil and questionnaire + Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires	Pfizer	Pre-clinical	22
Dacomitinib	Pfizer	Phase 2	51
Cabazitaxel	Sanofi	Phase 2	51
Retifanlimab	Incyte	Phase 2	49

Other Products from Pfizer